title: Usual Care for Adolescent Depression From Symptom Identification Through Treatment Initiation.
abstract: OBJECTIVE
  Published guidelines describing effective adolescent depression care in primary care settings include screening, assessment, treatment initiation, and symptom monitoring. It is unclear the extent to which these steps are documented in patient health records.
  
  
  OBJECTIVE
  To determine rates of appropriate follow-up care for adolescents with newly identified depression symptoms in 3 large health systems.
  
  
  METHODS
  In this analysis conducted from March to September 2014, structured data retrospectively extracted from electronic health records were analyzed for 3 months following initial symptom identification to determine whether the patient was followed up and, if so, whether treatment was initiated and/or symptoms were monitored. Records were collected from 2 large health maintenance organizations in the western United States and a network of community health centers in the Northeast. The study group included adolescents (N = 4612) with newly identified depression symptoms, defined as an elevated score on the Patient Health Questionnaire (≥ 10) and/or a diagnosis of depression.
  
  
  METHODS
  Rates of treatment initiation, symptom monitoring, and follow-up care documented within 3 months of initial symptom identification.
  
  
  RESULTS
  Among the 4612 participants, the mean (SD) age at index event was 16.0 (2.3) years, and 3060 were female (66%). Treatment was initiated for nearly two-thirds of adolescents (79% of those with a diagnosis of major depression; n =  023); most received psychotherapy alone or in combination with medications. However, in the 3 months following identification, 36% of adolescents received no treatment (n = 1678), 68% did not have a follow-up symptom assessment (n = 3136), and 19% did not receive any follow-up care (n = 854). Further, 40% of adolescents prescribed antidepressant medication did not have any documentation of follow-up care for 3 months (n = 356). Younger age (ages 15-17 years: odds ratio [OR], 0.78; 95% CI, 0.67-0.92 and ages 18-20 years: OR, 0.83; 95% CI, 0.70-0.99; P = .008), more severe initial symptoms (moderate: OR, 0.99; 95% CI, 0.82-1.21; moderate to severe: OR, 1.46; 95% CI, 1.19-1.80; and severe: OR, 2.14; 95% CI, 1.65-2.79; P < .001), and receiving a diagnosis (major depression/dysthymia: OR, 2.65; 95% CI, 2.20-3.20 and unspecified depression/adjustment disorder: OR, 1.75; 95% CI, 1.43-2.14; P < .001) were significantly associated with treatment initiation. Differences in rates of follow-up care were evident between sites (site 2: OR, 1.77; 95% CI, 1.45-2.16 and site 3: OR, 2.10; 95% CI, 1.72-2.57), suggesting that differences within health systems may also affect care received.
  
  
  CONCLUSIONS
  Most adolescents with newly identified depression symptoms received some treatment, usually including psychotherapy, within the first 3 months after identification. However, follow-up care was low and substantial variation existed between sites. These results raise concerns about the quality of care for adolescent depression.
authors.affiliation: New York University Child Study Center, Department of Child and Adolescent Psychiatry, New York University School of Medicine, New York.
authors.forename: Briannon C
authors.initials: BC
authors.lastname: O'Connor
authors.affiliation: New York University Child Study Center, Department of Child and Adolescent Psychiatry, New York University School of Medicine, New York.
authors.forename: R Eric
authors.initials: RE
authors.lastname: Lewandowski
authors.affiliation: National Committee for Quality Assurance, Washington, DC.
authors.forename: Stephanie
authors.initials: S
authors.lastname: Rodriguez
authors.affiliation: Evolent Health, Arlington, Virginia.
authors.forename: Aldo
authors.initials: A
authors.lastname: Tinoco
authors.affiliation: Children's Hospital of Eastern Ontario Research Institute, Ottawa, Ontario, Canada.
authors.forename: William
authors.initials: W
authors.lastname: Gardner
authors.affiliation: New York University Child Study Center, Department of Child and Adolescent Psychiatry, New York University School of Medicine, New York.
authors.forename: Kimberly
authors.initials: K
authors.lastname: Hoagwood
authors.affiliation: New York University Child Study Center, Department of Child and Adolescent Psychiatry, New York University School of Medicine, New York.
authors.forename: Sarah Hudson
authors.initials: SH
authors.lastname: Scholle
mesh_terms: D000293:Adolescent; D000294:Adolescent Behavior; D000928:Antidepressive Agents / Q000008:administration & dosage*; D003866:Depressive Disorder / Q000175:diagnosis / Q000628:therapy*; D057286:Electronic Health Records; D005260:Female; D005500:Follow-Up Studies; D006279:Health Maintenance Organizations; D006801:Humans; D008297:Male; D011320:Primary Health Care / Q000379:methods / Q000706:statistics & numerical data*; D011613:Psychotherapy / Q000706:statistics & numerical data*; D012189:Retrospective Studies; D011795:Surveys and Questionnaires; D014481:United States
chemical_list: D000928:Antidepressive Agents
references.citation: JAMA. 2014 Aug 27;312(8):809-16
references.pmid: 25157724
references.citation: J Am Acad Child Adolesc Psychiatry. 1995 Mar;34(3):312-21
references.pmid: 7896672
references.citation: Am J Prev Med. 2006 Dec;31(6 Suppl 1):S143-51
references.pmid: 17175409
references.citation: Am J Psychiatry. 2002 Sep;159(9):1548-55
references.pmid: 12202276
references.citation: J Am Acad Child Adolesc Psychiatry. 2006 Dec;45(12):1427-39
references.pmid: 17135988
references.citation: Psychiatr Serv. 2016 Jun 1;67(6):636-41
references.pmid: 26876655
references.citation: J Am Acad Child Adolesc Psychiatry. 2006 Dec;45(12):1404-11
references.pmid: 17135985
references.citation: MMWR Surveill Summ. 2010 Jun 4;59(5):1-142
references.pmid: 20520591
references.citation: J Clin Child Adolesc Psychol. 2005 Sep;34(3):362-79
references.pmid: 16026210
references.citation: J Am Acad Child Adolesc Psychiatry. 2010 Oct;49(10):980-9
references.pmid: 20855043
references.citation: J Am Acad Child Adolesc Psychiatry. 2007 Nov;46(11):1503-26
references.pmid: 18049300
references.citation: Pediatrics. 2012 Dec;130(6):e1541-8
references.pmid: 23166342
references.citation: JAMA. 1999 May 12;281(18):1707-13
references.pmid: 10328070
references.citation: Pediatrics. 2009 Apr;123(4):1223-8
references.pmid: 19336383
references.citation: Depress Anxiety. 2012 Oct;29(10):906-13
references.pmid: 22753313
references.citation: J Affect Disord. 1998 Sep;50(2-3):97-108
references.pmid: 9858069
references.citation: Pediatrics. 2013 Mar;131 Suppl 1:S38-49
references.pmid: 23457148
references.citation: Arch Gen Psychiatry. 1996 Apr;53(4):339-48
references.pmid: 8634012
references.citation: J Abnorm Psychol. 1993 Feb;102(1):133-44
references.pmid: 8436689
references.citation: JAMA. 2005 Jan 19;293(3):311-9
references.pmid: 15657324
references.citation: Pediatrics. 1992 Mar;89(3):480-5
references.pmid: 1371342
references.citation: Pediatrics. 2007 Nov;120(5):e1313-26
references.pmid: 17974724
references.citation: Pediatrics. 2010 Dec;126(6):1117-23
references.pmid: 21041282
references.citation: J Am Acad Child Adolesc Psychiatry. 1993 May;32(3):521-9
references.pmid: 8496115
references.citation: Pediatrics. 2010 Jun;125 Suppl 3:S87-108
references.pmid: 20519566
references.citation: Psychiatr Serv. 2015 Feb 1;66(2):193-6
references.pmid: 25642614
references.citation: Psychol Med. 1995 Nov;25(6):1171-80
references.pmid: 8637947
references.citation: Pediatrics. 2013 Oct;132(4):e996-e1009
references.pmid: 24043282
references.citation: JAMA. 2002 Sep 25;288(12):1508-12
references.pmid: 12243638